Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating Activities    
Net loss $ (13,900) $ (11,098)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,111 3,124
Amortization of deferred lease incentive (34) (23)
Deferred income tax expense 9 9
Provision for doubtful accounts 169 37
Reserve for note receivable 350 0
Provision for excess and slow moving inventory 12 (54)
Stock-based compensation expense 1,604 4,268
Deferred rent 2 84
Accrued interest receivable 0 (3)
Amortization of debt issuance and discount costs 631 636
Loss on early extinguishment of debt 182 321
Warrant modification expense 803 0
Change in fair value of warrant liability (404) (797)
Fair value adjustment of contingent consideration liability 35 (8,634)
Gain on sale of assets (1,700) (3,311)
Changes in operating assets and liabilities:    
Accounts receivable (499) (254)
Inventory 414 (643)
Prepaid expenses and other assets 439 55
Accounts payable (1,023) (48)
Accrued expenses and other current liabilities (1,000) 1,297
Other long-term liabilities 0 1,000
Net Cash Used in Operating Activities (9,799) (14,034)
Investing Activities    
Proceeds from sale of assets 3,412 4,103
Purchase of improvements and equipment (126) (573)
Issuance of bridge loan (350) (500)
Net Cash Provided by Investing Activities 2,936 3,030
Financing Activities    
Contingent purchase price payments (675) (2,573)
Repayment of long-term debt (1,618) (1,748)
Loss on early extinguishment of debt (32) (52)
Net proceeds from issuance of common stock 5,865 0
Payment of withholding taxes related to stock-based employee compensation (151) (2)
Net Cash Provided by (Used in) Financing Activities 3,389 (4,375)
Net Decrease in Cash and Cash Equivalents (3,474) (15,379)
Cash and Cash Equivalents - Beginning of period 5,580 26,080
Cash and Cash Equivalents - End of period 2,106 10,701
Supplemental Disclosure of Cash Flows Information    
Interest 1,008 1,221
Non-cash investing and financing activities:    
2016 Accrued bonus awarded in equity 374 0
2015 Accrued bonus awarded in equity 0 474
Common stock issued for contingent purchase price payments $ 1,175 $ 2,574